Literature DB >> 1707931

Involvement of the 55- and 75-kDa tumor necrosis factor receptors in the generation of lymphokine-activated killer cell activity and proliferation of natural killer cells.

B Naume1, R Shalaby, W Lesslauer, T Espevik.   

Abstract

In this study we investigated the expression of the 55 kDa (p55) and the 75 kDa (p75) TNF receptors in CD56+ NK cells and their role in NK and lymphokine-activated killer cells cell functions. By using mAb against the p55 and p75 TNF-R, NK cells were found to express both p55 and p75 upon activation, and both receptors were involved in the generation of lymphokine-activated killer cells activity. Proliferative activity of IL-2 stimulated NK cells was inhibited by anti-TNF-alpha mAb, indicating that endogenously produced TNF-alpha is important for optimal proliferation of NK cells. Furthermore, addition of rTNF-alpha increased the IL-2-induced proliferation of NK cells. mAb to p55 and p75 inhibited the IL-2-induced proliferation indicating that both TNF-R are involved in mediating this effect.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1707931

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Current imaging strategies in rheumatoid arthritis.

Authors:  Merissa N Zeman; Peter Jh Scott
Journal:  Am J Nucl Med Mol Imaging       Date:  2012-03-28

2.  Differential secretion of TNF-alpha and IFN-gamma by human peripheral blood-derived NK subsets and association with functional maturation.

Authors:  A Jewett; X H Gan; L T Lebow; B Bonavida
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Elevated levels of soluble tumour necrosis factor receptor I in blister fluids of bullous pemphigoid and suction blisters.

Authors:  A Zentner; J Rendl; I Grelle; R Dummer; E B Bröcker; D Zillikens
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

Review 4.  Role of proinflammatory cytokines in the pathophysiology of osteoarthritis.

Authors:  Mohit Kapoor; Johanne Martel-Pelletier; Daniel Lajeunesse; Jean-Pierre Pelletier; Hassan Fahmi
Journal:  Nat Rev Rheumatol       Date:  2010-11-30       Impact factor: 20.543

5.  The two different receptors for tumor necrosis factor mediate distinct cellular responses.

Authors:  L A Tartaglia; R F Weber; I S Figari; C Reynolds; M A Palladino; D V Goeddel
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-15       Impact factor: 11.205

6.  Multifaceted inhibition of anti-tumour immune mechanisms by soluble tumour necrosis factor receptor type I.

Authors:  C L Selinsky; K L Boroughs; W A Halsey; M D Howell
Journal:  Immunology       Date:  1998-05       Impact factor: 7.397

7.  Relationship between soluble tumor necrosis factor (TNF) receptors and TNF alpha during immunotherapy with interleukin-2 and/or interferon alpha.

Authors:  R Landmann; U Keilholz; C Scheibenbogen; M Brockhaus; H Gallati; H Denz; M Bargetzi; C Ludwig
Journal:  Cancer Immunol Immunother       Date:  1994-02       Impact factor: 6.968

8.  Unmasking of a protective tumor necrosis factor receptor I-mediated signal in the collagen-induced arthritis model.

Authors:  Cheryll Williams-Skipp; Thiagarajan Raman; Robert J Valuck; Herschel Watkins; Brent E Palmer; Robert I Scheinman
Journal:  Arthritis Rheum       Date:  2009-02

9.  Soluble TNF receptor production by activated T lymphocytes: differential effects of acute and chronic exposure to TNF.

Authors:  A P Cope; D Aderka; D Wallach; M Kahan; N R Chu; F M Brennan; M Feldmann
Journal:  Immunology       Date:  1995-01       Impact factor: 7.397

10.  High-dose continuous venous infusion of interleukin-2: influence of dose and infusion rate on tumoricidal function and lymphocyte subsets.

Authors:  W C Mertens; D Banerjee; N al-Mutter; L Stitt; V H Bramwell; P K Lala
Journal:  Cancer Immunol Immunother       Date:  1995-11       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.